Busse Paul M MD entered the industry of Specialty Outpatient Clinics, Nec in 1983 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Specialty Outpatient Clinics, Nec. For further clarification, the SIC classifies this business under the code 8093 and described it as a Specialty Outpatient Clinics, Nec. The business provides service to the B2C market.
To acquire more information, please contact Paul Busse by calling (617) 667-9550 during business hours. You can also write to the business’ Single Location at 330 Brookline Avenue, Boston, Massachusetts MA 02215. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Busse Paul M MD |
| Representative: | Paul Busse |
| Place of Business: | 330 Brookline Avenue, Boston, MA 02215 |
| Contact Number: | (617) 667-9550 |
| Type of Service: | Specialty Outpatient Clinics, Nec |
| SIC Number: | 8093 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1983 |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Busse Paul M MD is a company operating from Suffolk, Massachusetts providing professional Specialty Outpatient Clinics, Nec and relevant B2C variables. It was founded in 1983 and registered with the SIC code 8093 as Specialty Outpatient Clinics, Nec, and with the NAICS code 6211110 as Specialty Outpatient Clinics, Nec.
With a current employee count of 1 to 4, Busse Paul M MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Paul Busse at (617) 667-9550 for related queries, or to locate its Single Location using the coordinates 42.340759,-71.105216.
The Single Location can also be found at the street address 330 Brookline Avenue in Boston, Massachusetts 02215 and can be engaged online through the company website at , the company Twitter , and Facebook page .